Clinical Trials in Boston

Showing 8721-8740 of 17,836 trials

COMPLETEDNA< 1 mile

Disseminating an Evidence-based Tobacco Control Intervention for School Teachers in India

NCT05346991

Disseminating an evidence-based tobacco control intervention for School Teachers

Tobacco Use Cessation

Glorian Sorensen1,102 participantsStarted Jun 2018

Boston, Massachusetts, United States • Mumbai, India

COMPLETEDNA< 1 mile

Testing Feasibility of Motivational Interviewing for Patient-Reported Cancer Pain Goals

NCT03736746

This research study is evaluating the acceptability and feasibility of using a cognitive behavioral intervention called Motivational Interviewing to help persons with pain from cancer set goals for managing that pain.

Other Cancer

Dana-Farber Cancer Institute54 participantsStarted Nov 2018

Boston, Massachusetts, United States

COMPLETEDPhase 2/3< 1 mile

A Study of the Efficacy and Safety of Hematopoietic Stem Cells Transduced With Lenti-D Lentiviral Vector for the Treatment of Cerebral Adrenoleukodystrophy (CALD)

NCT01896102

This trial assessed the efficacy and safety of autologous cluster of differentiation 34 (CD34+) hematopoietic stem cells, transduced ex-vivo with Lenti-D lentiviral vector (also called elivaldogene autotemcel or eli-cel), for the treatment of cerebral adrenoleukodystrophy (CALD). A participant's blood stem cells were collected and modified (transduced) using the Lenti-D lentiviral vector encoding human adrenoleukodystrophy protein. After modification (transduction) with the Lenti-D lentiviral vector, the cells were transplanted back into the participant following myeloablative conditioning. Participants in this study will be continuously followed in study LTF-304.

Cerebral Adrenoleukodystrophy (CALD)

Genetix Biotherapeutics Inc.32 participantsStarted Aug 2013

Los Angeles, California, United States • Boston, Massachusetts, United States • Minneapolis, Minnesota, United States +5 more locations

Disseminating an Evidence-based Tobacco Control Intervention for School Teachers in India

Testing Feasibility of Motivational Interviewing for Patient-Reported Cancer Pain Goals

A Study of the Efficacy and Safety of Hematopoietic Stem Cells Transduced With Lenti-D Lentiviral Vector for the Treatment of Cerebral Adrenoleukodystrophy (CALD)

Find Trials by Condition in Boston

RAPAMYCIN FOR KIDNEY ANGIOMYOLIPOMAS

Tau/P-Tau and Neurocognitive Outcomes in Children

Safety and Tolerability of WVE-120102 in Patients With Huntington's Disease

Evaluating the Infectivity, Safety, and Immunogenicity of Recombinant Live-Attenuated RSV Vaccines RSV ΔNS2/Δ1313/I1314L or RSV 276 in RSV-Seronegative Infants 6 to 24 Months of Age

Compare Efficacy/Safety of Repeat Doses of Ferumoxytol With Iron Sucrose in CKD Subjects With IDA and on Hemodialysis

Convalescent Plasma to Stem Coronavirus (CSSC-001)

Integrase and Maraviroc Intensification in Neurocognitive Dysfunction (InMIND)

Effect of AMR101 (Ethyl Icosapentate) on Triglyceride (Tg) Levels in Patients on Statins With High Tg Levels (≥ 200 and < 500 mg/dL)

Efficacy Study of Arbaclofen to Treat Spasticity in Multiple Sclerosis

BRAVO Study: Laquinimod Double-blind Placebo-controlled Study in Participants With Relapsing-Remitting Multiple Sclerosis (RRMS) With a Rater Blinded Reference Arm of Interferon β-1a (Avonex®)

An Extension Study in Participants With Moderate to Severe Rheumatoid Arthritis

One Year, Open Label, Dose Escalation Long-term Safety Study in Multiple Sclerosis (MS) Subjects With Spasticity

Ph 1-2 Study ADI-PEG 20 Plus FOLFOX in Subjects With Advanced GI Malignancies Focusing on Hepatocellular Carcinoma

Study Comparing the Efficacy and Safety of Insulin Glargine (Basal Insulin)/Lixisenatide (GLP-1 Receptor Agonist) Combination (Soliqua™) in Patients With Type 2 Diabetes Mellitus (T2DM)

Efficacy and Safety of AMR101 (Ethyl Icosapentate) in Patients With Fasting Triglyceride (Tg) Levels ≥ 500 and ≤ 2000 mg/dL

The ADAPT Study: Assessment of the DiAgnostic Performance of DeepVessel FFR in SuspecTed Coronary Artery Disease

Twelve -Month Study Observing How Insulin-naïve Patients With Type 2 Diabetes Mellitus Manage Diabetes Using Toujeo® After Oral Antidiabetic Drug Failure, the Side Effect of Toujeo®, and The Cost.